Small molecules represent a significant proportion of drug discovery and development in the search for new chemical entities, in addition to the extensive work involved in the regulatory filings of generics. Targeted quantitation assays are a critical part of an optimal workflow, which is required to successfully develop a small molecule drug. These targeted quantitation analyses must be done in biological matrices, which can often create analytical challenges. This study reports on the development of a sensitive, robust, reliable, and reproducible LC-MS/MS assay for multiple drug standards in rat plasma.
The application note demonstrates how the TSQ Altis triple quadrupole mass spectrometer provides the sensitivity and reproducibility required in the analysis of pharmaceutical compounds.
To download your copy of this application note complete the form opposite.
Registrants for this application note are covered by the Eclipse Business Media Privacy Policy.
Eclipse Business Media Ltd, Regd in England, No. 06513189, Woodview, Bull Lane Industrial Estate, Sudbury, CO10 0FD, United Kingdom, T +44 (0)161 818 7434, info@sepscience.com
Eclipse Business Media Ltd needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy or contact privacy@labxmediagroup.com
Copyright © 2025. All rights reserved